157 related articles for article (PubMed ID: 32810764)
1. Human epidermal growth factor receptor 2 fluorescence in situ hybridization and P57KIP2 immunohistochemistry using tissue microarray: Improving histopathological subtyping of hydatidiform mole.
López CL; Figueira Gouvêa AL; Rodrigues FR; Braga A; Valente Machado MD; Lopes VS
Placenta; 2020 Sep; 99():166-172. PubMed ID: 32810764
[TBL] [Abstract][Full Text] [Related]
2. Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles.
Chen KH; Hsu SC; Chen HY; Ng KF; Chen TC
Biochem Biophys Res Commun; 2014 Apr; 446(2):555-60. PubMed ID: 24613849
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization.
LeGallo RD; Stelow EB; Ramirez NC; Atkins KA
Am J Clin Pathol; 2008 May; 129(5):749-55. PubMed ID: 18426735
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM
Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308
[TBL] [Abstract][Full Text] [Related]
5. Recurrent Androgenetic Complete Hydatidiform Moles with p57
Li MW; Li F; Cheng J; Wang F; Zhou P
Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065
[TBL] [Abstract][Full Text] [Related]
6. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT
Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919
[TBL] [Abstract][Full Text] [Related]
8. Tetraploid partial hydatidiform mole: a case report and review of the literature.
Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM
Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726
[TBL] [Abstract][Full Text] [Related]
9. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas.
Fukunaga M
Arch Pathol Lab Med; 2004 Aug; 128(8):897-900. PubMed ID: 15270611
[TBL] [Abstract][Full Text] [Related]
11. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.
Merchant SH; Amin MB; Viswanatha DS; Malhotra RK; Moehlenkamp C; Joste NE
Hum Pathol; 2005 Feb; 36(2):180-6. PubMed ID: 15754295
[TBL] [Abstract][Full Text] [Related]
12. A case of complete hydatidiform mole in a perimenopausal woman with diagnostic usefulness of p57(kip2) immunohistochemistry and HER2 fluorescent in situ hybridization.
Hatanaka K; Higashi M; Fujibayashi M; Hori S; Yoshioka T; Umekita Y; Tanimoto A
Pathol Res Pract; 2012 Feb; 208(2):118-20. PubMed ID: 22197173
[TBL] [Abstract][Full Text] [Related]
13. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification.
Genest DR; Dorfman DM; Castrillon DH
J Reprod Med; 2002 May; 47(5):342-6. PubMed ID: 12063872
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of p57
Madi JM; Braga AR; Paganella MP; Litvin IE; Da Ros Wendland EM
Syst Rev; 2016 Oct; 5(1):169. PubMed ID: 27716354
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
16. Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry.
Crisp H; Burton JL; Stewart R; Wells M
Histopathology; 2003 Oct; 43(4):363-73. PubMed ID: 14511255
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of p57 immunohistochemistry and DNA ploidy analysis by fluorescence in situ hybridisation in hydatidiform moles.
Wong YP; Chia WK; Selimin A; Chia PY; Mustangin M; Shuib S; Khong TY; Tan GC
Malays J Pathol; 2021 Dec; 43(3):341-351. PubMed ID: 34958055
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation.
Nguyen NM; Zhang L; Reddy R; Déry C; Arseneau J; Cheung A; Surti U; Hoffner L; Seoud M; Zaatari G; Bagga R; Srinivasan R; Coullin P; Ao A; Slim R
J Med Genet; 2014 Sep; 51(9):623-34. PubMed ID: 25097207
[TBL] [Abstract][Full Text] [Related]
19. Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes.
Zainal N; Kampan NC; Rose IM; Ghazali R; Shafiee MN; Yussoff NH; Tamil A; Jamil MA; Hussin NH
Horm Mol Biol Clin Investig; 2021 May; 42(3):311-316. PubMed ID: 34018382
[TBL] [Abstract][Full Text] [Related]
20. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
